Clinical studies recruiting near Springdale

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Highlands Oncology Group, PA · Pfizer · NCT07028853 Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · Highlands Oncology Group, PA · Pfizer · NCT07421700 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Highlands Oncology Group · Eli Lilly and Company · NCT06890598 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Highlands Oncology Group, PA · Pfizer · NCT07144280 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Highlands Oncology Group · Pfizer · NCT06629779 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Deg
Phase 3 · Adverum Clinical Site 198 · Adverum Biotechnologies, Inc. · NCT07482176 Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Antica
Phase 1/Phase 2 · Highlands Oncology Group · Pfizer · NCT07227415 Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Phase 2 · Highlands Oncology Group · Black Diamond Therapeutics, Inc. · NCT07326566 Delivering HOPE (Helping Women Optimize Prenatal Equity)
NA · Community Clinic · University of Arkansas · NCT06814509 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Highlands Oncology Group · Eli Lilly and Company · NCT06119581 A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Phase 3 · Highlands Oncology Group · Daiichi Sankyo · NCT06203210 A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R)
Phase 3 · Highlands Oncology Group ( Site 5405) · Merck Sharp & Dohme LLC · NCT05947851 Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Phase 2 · Highlands Oncology Group · SWOG Cancer Research Network · NCT05633615 A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherap
Phase 2/Phase 3 · Highlands Oncology Group - Springdale /ID# 277132 · AbbVie · NCT07155187 Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Inva
Phase 2 · Highlands Oncology Group · National Cancer Institute (NCI) · NCT07061964 A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Phase 1 · Highlands Oncology Group · Seagen, a wholly owned subsidiary of Pfizer · NCT04389632 Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Highlands Oncology Group · Pfizer · NCT07222800 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With
Phase 3 · Highlands Oncology Group · National Cancer Institute (NCI) · NCT07198074 Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer
Phase 1/Phase 2 · Highlands Oncology Group, PA · Pfizer · NCT07227298 A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Phase 3 · Highlands Oncology Group · Janssen Research & Development, LLC · NCT07518186 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Highlands Oncology Group · National Cancer Institute (NCI) · NCT05987241 Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Mon
Phase 3 · Highlands Oncology Group · ImmunityBio, Inc. · NCT06745908 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Highlands Oncology Group - Springdale · Mirati Therapeutics Inc. · NCT04613596 Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
Phase 2 · Highlands Oncology Group, PA · University of Arkansas · NCT05952934 A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Parti
Phase 3 · Highlands Oncology Group-Research Department ( Site 0062) · Merck Sharp & Dohme LLC · NCT06312137 Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy T
Phase 2 · Highlands Oncology Group · National Cancer Institute (NCI) · NCT06770582 A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants
Phase N/A · Arkansas Children's Northwest · Arkansas Children's Hospital Research Institute · NCT07422337 Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adul
Phase 2/Phase 3 · Highlands Oncology Group · Pfizer · NCT07226999

Look up another city

Look up another condition